[ Price : $8.95]
Federal Register Notice: FDAs Tobacco Products Scientific Advisory Committee will meet 11/2 to discuss the use of dissolvable toba...[ Price : $8.95]
OncoGenex completes an amendment of its Special Protocol Assessment with FDA to expand the inclusion criteria for its SATURN clini...[ Price : $8.95]
Amneal Pharmaceuticals releases a 400 mg and 600 mg first-to-market generic antiepileptic felbamate.[ Price : $8.95]
FDA schedules a 10/24 public meeting to hear comment on proposed recommendations for the PDUFA 5 reauthorization.[ Price : $8.95]
FDA issues a compliance policy guide clarifying how it is exercising enforcement discretion for unapproved drugs introduced into t...[ Price : $8.95]
Shionogi Pharma and Cima Labs file a patent infringement suit against Mylan Pharmaceuticals over an ANDA it submitted for a generi...[ Price : $8.95]
Consulting editor John Scharmann reports on current expansion of FDAs field staff and investigational capabilities.[ Price : $8.95]
A new FDA drug safety alert says Sanofi-Aventis Anzemet (dolasetron mesylate injection) should no longer be used to prevent nausea...